TARONE, LIDIA
TARONE, LIDIA
BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE
A chimeric human/dog-DNA vaccine against CSPG4 induces immunity with therapeutic potential in comparative preclinical models of osteosarcoma
2023-01-01 Tarone, Lidia; Giacobino, Davide; Camerino, Mariateresa; Maniscalco, Lorella; Iussich, Selina; Parisi, Lorenza; Giovannini, Giuseppe; Dentini, Alfredo; Bolli, Elisabetta; Quaglino, Elena; Merighi, Irene Fiore; Morello, Emanuela; Buracco, Paolo; Riccardo, Federica; Cavallo, Federica
Antigen mimicry as an effective strategy to induce CSPG4-targeted immunity in dogs with oral melanoma: a veterinary trial
2022-01-01 Riccardo, Federica; Tarone, Lidia; Camerino, Mariateresa; Giacobino, Davide; Iussich, Selina; Barutello, Giuseppina; Arigoni, Maddalena; Conti, Laura; Bolli, Elisabetta; Quaglino, Elena; Merighi, Irene Fiore; Morello, Emanuela; Dentini, Alfredo; Ferrone, Soldano; Buracco, Paolo; Cavallo, Federica
Cancer stem cell immunology and immunotherapy: Harnessing the immune system against cancer's source
2019-01-01 Ruiu R.; Tarone L.; Rolih V.; Barutello G.; Bolli E.; Riccardo F.; Cavallo F.; Conti L.
Canine Melanoma and Osteosarcoma Immunotherapy by Means of In Vivo DNA Electroporation
2021-01-01 Tarone, Lidia; Buracco, Paolo; Cavallo, Federica; Riccardo, Federica
Canine Melanoma Immunology and Immunotherapy: Relevance of Translational Research
2022-01-01 Tarone L.; Giacobino D.; Camerino M.; Ferrone S.; Buracco P.; Cavallo F.; Riccardo F.
Difference in outcome between curative intent vs marginal excision as a first treatment in dogs with oral malignant melanoma and the impact of adjuvant CSPG4-DNA electrovaccination: A retrospective study on 155 cases
2021-01-01 Giacobino D.; Camerino M.; Riccardo F.; Cavallo F.; Tarone L.; Martano M.; Dentini A.; Iussich S.; Lardone E.; Franci P.; Valazza A.; Manassero L.; Del Magno S.; De Maria R.; Morello E.; Buracco P.
Difference in outcome between curative intent vs marginal excision as a first treatment in dogs with oral malignant melanoma and the impact of adjuvant CSPG4-DNA electrovaccination: A retrospective study on 155 cases
2021-01-01 Giacobino D.; Camerino M.; Riccardo F.; Cavallo F.; Tarone L.; Martano M.; Dentini A.; Iussich S.; Lardone E.; Franci P.; Valazza A.; Manassero L.; Del Magno S.; De Maria R.; Morello E.; Buracco P.
Identification of CSPG4 as a promising target for translational combinatorial approaches in osteosarcoma
2019-01-01 Riccardo F, Tarone L, Iussich S, Giacobino D, Arigoni M, Sammartano F, Morello E, Martano M, Gattino F, De Maria R., Ferrone S, Buracco P, Cavallo F.
Immunization against ROS1 by DNA electroporation impairs K-ras-driven lung adenocarcinomas
2020-01-01 Riccardo F.; Barutello G.; Petito A.; Tarone L.; Conti L.; Arigoni M.; Musiu C.; Izzo S.; Volante M.; Longo D.L.; Merighi I.F.; Papotti M.; Cavallo F.; Quaglino E.
Improving Osteosarcoma Treatment: Comparative Oncology in Action
2022-01-01 Tarone, Lidia; Mareschi, Katia; Tirtei, Elisa; Giacobino, Davide; Camerino, Mariateresa; Buracco, Paolo; Morello, Emanuela; Cavallo, Federica; Riccardo, Federica
Naturally occurring cancers in pet dogs as pre-clinical models for cancer immunotherapy
2019-01-01 Tarone L.; Barutello G.; Iussich S.; Giacobino D.; Quaglino E.; Buracco P.; Cavallo F.; Riccardo F.
Prognostic impact of bone invasion in canine oral malignant melanoma treated by surgery and anti-CSPG4 vaccination: A retrospective study on 68 cases (2010–2020)
2022-01-01 Camerino M.; Giacobino D.; Manassero L.; Iussich S.; Riccardo F.; Cavallo F.; Tarone L.; Olimpo M.; Lardone E.; Martano M.; Del Magno S.; Buracco P.; Morello E.
Strengths and weaknesses of pre-clinical models for human melanoma treatment: Dawn of dogs’ revolution for immunotherapy
2018-01-01 Barutello, Giuseppina; Rolih, Valeria; Arigoni, Maddalena; Tarone, Lidia; Conti, Laura; Quaglino, Elena; Buracco, Paolo; Cavallo, Federica; Riccardo, Federica*
Toll-like receptor 2 at the crossroad between cancer cells, the immune system, and the microbiota
2020-01-01 Di Lorenzo A.; Bolli E.; Tarone L.; Cavallo F.; Conti L.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A chimeric human/dog-DNA vaccine against CSPG4 induces immunity with therapeutic potential in comparative preclinical models of osteosarcoma | 2023 | Tarone, Lidia; Giacobino, Davide; Camerino, Mariateresa; Maniscalco, Lorella; Iussich, Selina; Parisi, Lorenza; Giovannini, Giuseppe; Dentini, Alfredo; Bolli, Elisabetta; Quaglino, Elena; Merighi, Irene Fiore; Morello, Emanuela; Buracco, Paolo; Riccardo, Federica; Cavallo, Federica | |
| Antigen mimicry as an effective strategy to induce CSPG4-targeted immunity in dogs with oral melanoma: a veterinary trial | 2022 | Riccardo, Federica; Tarone, Lidia; Camerino, Mariateresa; Giacobino, Davide; Iussich, Selina; Barutello, Giuseppina; Arigoni, Maddalena; Conti, Laura; Bolli, Elisabetta; Quaglino, Elena; Merighi, Irene Fiore; Morello, Emanuela; Dentini, Alfredo; Ferrone, Soldano; Buracco, Paolo; Cavallo, Federica | |
| Cancer stem cell immunology and immunotherapy: Harnessing the immune system against cancer's source | 2019 | Ruiu R.; Tarone L.; Rolih V.; Barutello G.; Bolli E.; Riccardo F.; Cavallo F.; Conti L. | |
| Canine Melanoma and Osteosarcoma Immunotherapy by Means of In Vivo DNA Electroporation | 2021 | Tarone, Lidia; Buracco, Paolo; Cavallo, Federica; Riccardo, Federica | |
| Canine Melanoma Immunology and Immunotherapy: Relevance of Translational Research | 2022 | Tarone L.; Giacobino D.; Camerino M.; Ferrone S.; Buracco P.; Cavallo F.; Riccardo F. | |
| Difference in outcome between curative intent vs marginal excision as a first treatment in dogs with oral malignant melanoma and the impact of adjuvant CSPG4-DNA electrovaccination: A retrospective study on 155 cases | 2021 | Giacobino D.; Camerino M.; Riccardo F.; Cavallo F.; Tarone L.; Martano M.; Dentini A.; Iussich S.; Lardone E.; Franci P.; Valazza A.; Manassero L.; Del Magno S.; De Maria R.; Morello E.; Buracco P. | |
| Difference in outcome between curative intent vs marginal excision as a first treatment in dogs with oral malignant melanoma and the impact of adjuvant CSPG4-DNA electrovaccination: A retrospective study on 155 cases | 2021 | Giacobino D.; Camerino M.; Riccardo F.; Cavallo F.; Tarone L.; Martano M.; Dentini A.; Iussich S.; Lardone E.; Franci P.; Valazza A.; Manassero L.; Del Magno S.; De Maria R.; Morello E.; Buracco P. | |
| Identification of CSPG4 as a promising target for translational combinatorial approaches in osteosarcoma | 2019 | Riccardo F, Tarone L, Iussich S, Giacobino D, Arigoni M, Sammartano F, Morello E, Martano M, Gattino F, De Maria R., Ferrone S, Buracco P, Cavallo F. | |
| Immunization against ROS1 by DNA electroporation impairs K-ras-driven lung adenocarcinomas | 2020 | Riccardo F.; Barutello G.; Petito A.; Tarone L.; Conti L.; Arigoni M.; Musiu C.; Izzo S.; Volante M.; Longo D.L.; Merighi I.F.; Papotti M.; Cavallo F.; Quaglino E. | |
| Improving Osteosarcoma Treatment: Comparative Oncology in Action | 2022 | Tarone, Lidia; Mareschi, Katia; Tirtei, Elisa; Giacobino, Davide; Camerino, Mariateresa; Buracco, Paolo; Morello, Emanuela; Cavallo, Federica; Riccardo, Federica | |
| Naturally occurring cancers in pet dogs as pre-clinical models for cancer immunotherapy | 2019 | Tarone L.; Barutello G.; Iussich S.; Giacobino D.; Quaglino E.; Buracco P.; Cavallo F.; Riccardo F. | |
| Prognostic impact of bone invasion in canine oral malignant melanoma treated by surgery and anti-CSPG4 vaccination: A retrospective study on 68 cases (2010–2020) | 2022 | Camerino M.; Giacobino D.; Manassero L.; Iussich S.; Riccardo F.; Cavallo F.; Tarone L.; Olimpo M.; Lardone E.; Martano M.; Del Magno S.; Buracco P.; Morello E. | |
| Strengths and weaknesses of pre-clinical models for human melanoma treatment: Dawn of dogs’ revolution for immunotherapy | 2018 | Barutello, Giuseppina; Rolih, Valeria; Arigoni, Maddalena; Tarone, Lidia; Conti, Laura; Quaglino, Elena; Buracco, Paolo; Cavallo, Federica; Riccardo, Federica* | |
| Toll-like receptor 2 at the crossroad between cancer cells, the immune system, and the microbiota | 2020 | Di Lorenzo A.; Bolli E.; Tarone L.; Cavallo F.; Conti L. |